FGFR4 and neoplasm: The polymorphism c.1162G>A; p.Gly388Arg of the Fgfr4 gene has been reported as pathogenic for cancer and tumor progression and is associated with a significant reduction in disease-free survival (Ulaganathan et al., 2015).